Liver cancer is a serious and deadly cancer ... pembrolizumab, and transarterial chemoembolization (TACE) significantly improves progression-free survival compared to TACE alone, addressing ...

Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

(Reuters) - Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer ... transarterial chemoembolization (TACE), which shrinks the cancer by delivering ...

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, ...